CLAIMS from a bio-medical businessman that his company could cure cancer and autism sparked a passionate debate at a Chamber of Commerce seminar yesterday.
Immuno Biotech CEO David Noakes suggested that the use of GcMAF could repair the body's immune system and act as a 'rifle-shot' to cure the diseases.
Mr Noakes claimed that more than 50 research papers had shown GcMAF, which is extracted from healthy human blood, could cure the diseases.
One doctor, who wished to remain anonymous, criticised the evidence presented by Mr Noakes.
'You've cherry-picked the research to support what you're saying, and the journal that has been published is very poor quality, whereas you have Cancer Research UK saying "if it sounds too good to be true it probably is",' he said.
But Mr Noakes responded: 'Cancer Research is a front man – it's rubbished the research saying it all depends on one person, but there are 119 other eminent scientists who have done their own research too.'